PlumX Metrics
Embed PlumX Metrics

Controversies in the Management of Functional Constipation in Children

Current Gastroenterology Reports, ISSN: 1534-312X, Vol: 21, Issue: 6, Page: 23
2019
  • 51
    Citations
  • 0
    Usage
  • 166
    Captures
  • 2
    Mentions
  • 10
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    51
  • Captures
    166
  • Mentions
    2
    • News Mentions
      2
      • News
        2
  • Social Media
    10
    • Shares, Likes & Comments
      10
      • Facebook
        10

Most Recent News

New Treatment For Functional Constipation In Children?

Functional constipation (FC), is frequent in children and diagnosed by Rome IV criteria has a worldwide prevalence of 14.4% (95% CI 11.2-17.6). In most children

Review Description

Purpose of review: Functional constipation (FC) in children is a common health problem with reported worldwide prevalence rates up to 32.2%. The majority of children with constipation respond to oral laxative treatment. After 5 years of intensive treatment, however, approximately 50% of children remain symptomatic. To discuss the evidence for new treatments in these children, including pre- and probiotics, pelvic physiotherapy, prucalopride, sacral nerve stimulation, and surgery, and to highlight the controversies surrounding them. Recent findings: Pre- and probiotics and prucalopride are not effective in the treatment of childhood constipation. Pelvic physiotherapy and sacral nerve stimulation are promising treatment options but larger trials are needed. Surgery for pediatric constipation is the treatment of last resort. Summary: Large, well-designed placebo-controlled trials with proper outcome measures, as suggested by the Rome foundation pediatric subcommittee on clinical trials, are necessary to provide more insight regarding the efficacy of new treatments in childhood constipation.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know